ONMD: 66% | OneMedNet shares are trading higher after the company announced that it has entered into a non-exclusive three-year Master Services Agreement with an undisclosed U.S.-based medical technology company.
CADL: 16% | Candel Therapeutics shares are trading higher after the FDA granted Orphan Drug Designation to CAN-3110.
AI: 14% | C3.ai shares are trading higher following strong Q4 earnings.